Abstract
Chemotherapy is the most widely used therapeutic strategy in the cancer treatment. The high incidence of cancer has led to a lot of immunotherapeutic and chemotherapeutic drugs to be developed and approved by U.S. Food and Drug Administration (FDA). This chapter presents different kinds of antineoplastic agents that have been approved or under development.
Keywords
- Renal Cell Carcinoma
- Acute Myeloid Leukemia
- Human Epidermal Growth Factor Receptor
- Chronic Myeloid Leukemia
- Hairy Cell Leukemia
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275–284
Gao Y, Xie J, Chen H, Gu S, Zhao R, Shao J, Lee J (2014) Nanotechnology-based intelligent drug design for cancer metastasis treatment. Biotechnol Adv 32:761–777
Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615–627
Mignani SM, Bryszewska M, Klajnert-Maculewicz B, Zablocka M, Majoral JP (2015) Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytic report. Biomacromolecules 16:1–27
Spencer DS, Puranik AS, Peppas NA (2015) Intelligent nanoparticles for advanced drug delivery in cancer treatment. Curr Opin Chem Eng 7:84–92
Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discovery 5:219–234
Szakacs G, Jakab K, Antal F, Sarkadi B (2008) Diagnostics of multidrug resistance in cancer. Pathol Oncol Res 4:251–257
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 The Author(s)
About this chapter
Cite this chapter
Feng, T., Zhao, Y. (2017). Clinical Anticancer Drugs for Cancer Treatment. In: Nanomaterial-Based Drug Delivery Carriers for Cancer Therapy. SpringerBriefs in Applied Sciences and Technology(). Springer, Singapore. https://doi.org/10.1007/978-981-10-3299-8_2
Download citation
DOI: https://doi.org/10.1007/978-981-10-3299-8_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-3297-4
Online ISBN: 978-981-10-3299-8
eBook Packages: EngineeringEngineering (R0)